holding its gains, no volume. not going to take much to spark this one back to above .05 imo.
undervalued for the technology alone. the sales are about to follow and i expect initial orders will surprise to the upside in US and asia.
new board will provide some great leverage in US to drive the support of the 'key opinion makers'
throw into the mix how long you think this technology (a perfect fit for resmed to expand its offerings) will stay off the radar of larger operators?
ground floor resmed lookalike, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
